Avocet targets growth after setback 18/03/2010
Gold producer Avocet Mining hopes its Wega acquisition will take 2010 group output to 200,000 oz after a flat nine months.
US pharmaceutical group Cephalon is to pay drug discoverer ImmuPharma £10 million upfront for an option on its Lupuzor lupus treatment.
The option deal gives Cephalon the right to obtain an exclusive worldwide licence for Lupuzor, which treats Lupus Erythematosus, a chronic auto-immune disease that damages skin, joints, blood vessels and the nervous system. If the US company exercises this option, it will then pay AIM-quoted ImmuPharma a one-time licence fee, payments if Lupuzor passes necessary regulatory milestones up to a maximum of £330 million and royalties on subsequent commercial sales.
ImmuPharma, which lost £1.5 million in the first half of this year, is now conducting a Phase IIb study of Lupuzor on patients in Europe and Latin America. If Cephalon exercises its option, it will take on all expenses for Phase III studies and commercialisation of the product.
Dimitri Dimitriou, chief executive officer of London-based ImmuPharma, proclaims this agreement ‘secures the future for our most advanced asset’. After a rough ride, ImmuPharma shares, which fell from 84.5p in early 2007 to 36.5p earlier this month, have bounced to 56.5p and should recover further if Lupuzor makes progress.
Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today with a half-price offer, and gain immediate access to all the recommendations, click here.
£7,277 That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The report reveals the top-earning chief executives and remuneration levels at AIM's most profitable and fastest-growing companies. It also examines constituent parts, including basic salary, bonus, pensions, benefits and share-based payments. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Gold producer Avocet Mining hopes its Wega acquisition will take 2010 group output to 200,000 oz after a flat nine months.
AIM shell China Evoline is understood to be contemplating the injection of some Chinese mining assets.
Small and medium sized company financier Ultimate Finance has increased first-half profits 36 per cent to £191,000 pre-tax.